查詢結果分析
來源資料
相關文獻
- 早期子宮內膜癌保守性治療的新知
- 子宮內膜癌保守性治療的檢視
- 黃體素在子宮內膜癌的角色
- 保留生育的子宮內膜癌治療
- 高劑量黃體素治療子宮內膜癌的病例報告
- Hysteroscopic Resection and Laparoscopy in Fertility-sparing Surgery for Early Endometrial Cancer and Complex Atypical Hyperplasia: A Single Institutional Experience
- 荷爾蒙補充治療與子宮內膜癌和乳癌的關係
- 黃體素應用於懷孕時會引起胎兒畸形嗎?
- 接受手術以及手術後放射線治療的子宮內膜癌預後的分析
- 靈芝水溶液對婦癌細胞生長之抑制效果
頁籤選單縮合
| 題 名 | 早期子宮內膜癌保守性治療的新知=Fertility-Sparing Treatment for Early Endometrial Cancer |
|---|---|
| 作 者 | 李耀泰; 陳福民; 郭宗正; | 書刊名 | 婦癌醫學期刊 |
| 卷 期 | 47 2018.04[民107.04] |
| 頁 次 | 頁41-46 |
| 分類號 | 417.281 |
| 關鍵詞 | 子宮內膜癌; 複雜性非典型內膜增生; 保留生育能力; 黃體素; Endometrial cancer; Complex atypical hyperplasia; Fertility-sparing; Progestin; |
| 語 文 | 中文(Chinese) |
| 中文摘要 | 子宮內膜癌的標準治療方式是分期手術。但患者如尚未完成生育,如何兼顧治療與生育,便顯得很重要。常用的保留生育的治療方法主要為口服黃體素,如予以me-droxyprogesterone acetate(MPA)或megestrol acetate(MA),其它治療方法尚有GnRHa、釋放levonorgestrel的子宮內避孕器、芳香酶抑制劑、metformin、子宮鏡內膜切除,或合併上述方法。同時建議,患者在完成治療後,在3個月內便能懷孕,一旦完成生育,宜立即切除子宮,避免復發。 |
| 英文摘要 | The standard treatment for endometrial cancer is staging operation. However, most young women with endometrial cancer have a strong desire to bear children. It is imperative to provide them with fertility-sparing options that will allow them the opportunity to get pregnant while at the same time provide them with adequate treatment of their cancer. The most common type of fertility-sparing management involves progestin via use of oral medroxyprogesterone acetate (MPA) or megestrol acetate (MA). Other therapies that have been evaluated include GnRH agonist, intrauterine devices (IUDs) releasing levonorgestrel, aromatase inhibitor, metformin, hysteroscopic tumor resection, or a combination of these therapies. It is recommended that patients attempt to conceive approximately 3 months after the completion of therapy. Hysterectomy is advisable after completion of childbirth, given the high recurrence rates after conservative treatment. |
本系統中英文摘要資訊取自各篇刊載內容。